Atypical/Malignant Meningioma
1 clinical trials · Condition
◉ Watch Atypical/Malignant Meningioma
| Record | Firm | Date |
|---|---|---|
| Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers (NCT03173950) | National Cancer Institute (NCI) | 2017-07-13 |
Track Atypical/Malignant Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.